{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:56:22Z","timestamp":1785452182370,"version":"3.56.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/lgt.0b013e31828543c5","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T22:01:27Z","timestamp":1363989687000},"page":"S78-S84","source":"Crossref","is-referenced-by-count":85,"title":["Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS"],"prefix":"10.1097","volume":"17","author":[{"given":"Hormuzd A.","family":"Katki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Castle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Fetterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Poitras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li C.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Raine-Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Gage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter K.","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210126","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer.","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"R2-9-20210126","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1470-2045(11)70078-X","article-title":"Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study.","volume":"12","author":"Kocken","year":"2011","journal-title":"Lancet Oncol"},{"key":"R3-9-20210126","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(96)08295-5","article-title":"Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia.","volume":"349","author":"Soutter","year":"1997","journal-title":"Lancet"},{"key":"R4-9-20210126","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ctrv.2003.07.008","article-title":"The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature.","volume":"30","author":"Paraskevaidis","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"R5-9-20210126","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1054\/bjoc.2000.1689","article-title":"Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia.","volume":"84","author":"Nobbenhuis","year":"2001","journal-title":"Br J Cancer"},{"key":"R6-9-20210126","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ygyno.2005.07.033","article-title":"Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence.","volume":"99","author":"Arbyn","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R7-9-20210126","first-page":"1849","article-title":"Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence Eur J C","volume":"43","author":"Strander","year":"2007","journal-title":"ancer"},{"key":"R8-9-20210126","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ejso.2010.08.135","article-title":"Predictors of recurrence in high-grade cervical lesions and a plan of management.","volume":"36","author":"Leguevaque","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"R9-9-20210126","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1471-0528.2008.01748.x","article-title":"HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia.","volume":"115","author":"Kitchener","year":"2008","journal-title":"BJOG"},{"key":"R10-9-20210126","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jcv.2011.06.021","article-title":"Human Papillomavirus genotype testing combined with cytology as a test of cure post treatment: the importance of a persistent viral infection.","volume":"52","author":"Jones","year":"2011","journal-title":"J Clin Virol"},{"key":"R11-9-20210126","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2006.10.011","article-title":"HPV16 and increased risk of recurrence after treatment for CIN.","volume":"104","author":"Gok","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R12-9-20210126","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00404-010-1530-1","article-title":"The role of HPV DNA testing in the follow-up of cervical intraepithelial neoplasia after loop electrosurgical excision procedure.","volume":"283","author":"Dogan","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"R13-9-20210126","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1471-0528.2007.01265.x","article-title":"Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia.","volume":"114","author":"Coupe","year":"2007","journal-title":"BJOG"},{"key":"R15-9-20210126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2010.12.003","article-title":"Alterations in human papillomavirus-related biomarkers after treatment of cervical intraepithelial neoplasia.","volume":"121","author":"Valasoulis","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R16-9-20210126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3802\/jgo.2012.23.4.217","article-title":"Early human papillomavirus testing predicts residualrecurrent disease after LEEP.","volume":"23","author":"Ryu","year":"2012","journal-title":"J Gynecol Oncol"},{"key":"R17-9-20210126","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/AOG.0b013e3182020704","article-title":"Clearance of human papillomavirus in women treated for cervical dysplasia.","volume":"117","author":"Moore","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R18-9-20210126","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ijc.26349","article-title":"Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment.","volume":"131","author":"Kreimer","year":"2012","journal-title":"Int J Cancer"},{"key":"R19-9-20210126","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ygyno.2012.01.015","article-title":"High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis.","volume":"125","author":"Kocken","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R20-9-20210126","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ajog.2008.11.031","article-title":"Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review.","volume":"200","author":"Chan","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R21-9-20210126","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/ijc.23824","article-title":"Post-treatment CIN: randomised clinical trial using hrHPV testing for prediction of residualrecurrent disease.","volume":"124","author":"Bais","year":"2009","journal-title":"Int J Cancer"},{"key":"R22-9-20210126","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1158\/1055-9965.EPI-05-0845","article-title":"Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.","volume":"15","author":"Kreimer","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R23-9-20210126","first-page":"S28","article-title":"Benchmarking CIN 3 risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines J Low Genit Tract D","volume":"17","author":"Katki","year":"2013","journal-title":"is"},{"key":"R24-9-20210126","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology.","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"R25-9-20210126","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/LGT.0b013e3182854253","article-title":"Five-year risks of CIN3 and cervical cancer among women with HPV testing of ASC-US Pap Results.","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R26-9-20210126","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/LGT.0b013e31825c31dd","article-title":"The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.","volume":"16","author":"Darragh","year":"2012","journal-title":"J Low Genit Tract Dis"}],"container-title":["Journal of Lower Genital Tract Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/LGT.0b013e31828543c5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:00:43Z","timestamp":1620957643000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00128360-201304001-00009"}},"subtitle":["Performance of HPV and Pap Cotesting in Posttreatment Management"],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":25,"journal-issue":{"issue":"Supplement 1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/lgt.0b013e31828543c5","relation":{},"ISSN":["1089-2591"],"issn-type":[{"value":"1089-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}